跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Magnesium valproate
首页
药物
Magnesium valproate
Magnesium valproate
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Use of transcriptome modifying agents and chemotherapy or radiotherapy against cancer
US 9186339 B2
申请人: GONZALEZ ALFONSO DUEÑAS
优先权: 2005
CN
EP
US
4 件公开
COMPOSITION AND METHOD FOR PRETREATING CANCER
EP 4483864 A1
申请人: VALCURIA AB
优先权: 2023
CN
EP
WO
4 件公开
METHOD FOR PRETREATING RELAPSING CANCER
EP 4282408 A1
申请人: VALCURIA AB
优先权: 2022
EP
US
2 件公开
METHODS FOR THE PREPARATION AND USE OF AQUEOUS SOLUTIONS OF MAGNESIUM VALPROATE HYDRATE AND L-CARNITINE
US 2011015267 A1
申请人: NELSON DEANNA JEAN
优先权: 2009
US
Magnesium valproate injection and preparation method thereof
CN 102784098 A
申请人: HUNAN PROVINCE XIANGZHONG PHARMACEUTICAL CO LTD
优先权: 2011
CN
MODIFIED RELEASE COMPOSITIONS OF MAGNESIUM VALPROATE
US 2013150444 A1
申请人: CADILA HEALTHCARE LTD
优先权: 2011
US
Magnesium valproate sustained-release tablet and preparing method thereof
CN 105456218 A
申请人: HEILONGJIANG ZHICHENG MEDICAL TECH CO LTD
优先权: 2015
CN
Sodium valproate tablets, and preparation method thereof
CN 107998096 A
申请人: HARVEST HUNAN PHARMACEUTICALS TECH CO LTD
优先权: 2017
CN
Method for preparing magnesium valproate slow-release micro-capsule
CN 108992411 A
申请人: LIU LI
优先权: 2017
CN
Magnesium valproate sustained release tablet and preparation process thereof
CN 107875133 A
申请人: HUNAN PROVINCE XIANGZHONG PHARMACEUTICAL CO LTD
优先权: 2017
CN
第 1 / 2 页
上一页
下一页
药物
反馈